Gentex price target lowered to $32 from $34 at JPMorgan

JPMorgan lowered the firm’s price target on Gentex (GNTX) to $32 from $34 and keeps a Neutral rating on the shares. The company reported a “surprisingly softer” set of Q4 results while also issuing 2025 guidance materially lower than consensus, the analyst tells investors in a research note. The firm says Gentex’s margin goal was again pushed out.